These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 11251695)

  • 41. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
    Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
    Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid initiation of gabapentin: a randomized, controlled trial.
    Fisher RS; Sachdeo RC; Pellock J; Penovich PE; Magnus L; Bernstein P
    Neurology; 2001 Mar; 56(6):743-8. PubMed ID: 11274308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause.
    Pinkerton JV; Kagan R; Portman D; Sathyanarayana R; Sweeney M;
    Menopause; 2014 Jun; 21(6):567-73. PubMed ID: 24149930
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study.
    McLean MJ; Morrell MJ; Willmore LJ; Privitera MD; Faught RE; Holmes GL; Magnus-Miller L; Bernstein P; Rose-Legatt A
    Epilepsia; 1999 Jul; 40(7):965-72. PubMed ID: 10403221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gabapentin for the treatment of pain in guillain-barré syndrome: a double-blinded, placebo-controlled, crossover study.
    Pandey CK; Bose N; Garg G; Singh N; Baronia A; Agarwal A; Singh PK; Singh U
    Anesth Analg; 2002 Dec; 95(6):1719-23, table of contents. PubMed ID: 12456446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gabapentin enacarbil and morphine administered in combination versus alone: a double-blind, randomized, pharmacokinetic, and tolerability comparison.
    Chen C; Upward J; Arumugham T; Stier B; Davy M
    Clin Ther; 2015 Feb; 37(2):349-57. PubMed ID: 25467190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy.
    Leach JP; Girvan J; Paul A; Brodie MJ
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):372-6. PubMed ID: 9120451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies.
    Trudeau V; Myers S; LaMoreaux L; Anhut H; Garofalo E; Ebersole J
    J Child Neurol; 1996 Nov; 11(6):470-5. PubMed ID: 9120226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study.
    Bone M; Critchley P; Buggy DJ
    Reg Anesth Pain Med; 2002; 27(5):481-6. PubMed ID: 12373695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial.
    Irving G; Jensen M; Cramer M; Wu J; Chiang YK; Tark M; Wallace M
    Clin J Pain; 2009; 25(3):185-92. PubMed ID: 19333167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized, double-blind, placebo-controlled, phase II trial of gabapentin enacarbil for migraine prophylaxis.
    Silberstein S; Goode-Sellers S; Twomey C; Saiers J; Ascher J
    Cephalalgia; 2013 Jan; 33(2):101-11. PubMed ID: 23165696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial.
    Tai Q; Kirshblum S; Chen B; Millis S; Johnston M; DeLisa JA
    J Spinal Cord Med; 2002; 25(2):100-5. PubMed ID: 12137213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of gabapentin on postoperative morphine consumption and pain after abdominal hysterectomy: a randomized, double-blind trial.
    Dierking G; Duedahl TH; Rasmussen ML; Fomsgaard JS; Møiniche S; Rømsing J; Dahl JB
    Acta Anaesthesiol Scand; 2004 Mar; 48(3):322-7. PubMed ID: 14982565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
    Mathew NT; Frishberg BM; Gawel M; Dimitrova R; Gibson J; Turkel C;
    Headache; 2005 Apr; 45(4):293-307. PubMed ID: 15836565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of social phobia with gabapentin: a placebo-controlled study.
    Pande AC; Davidson JR; Jefferson JW; Janney CA; Katzelnick DJ; Weisler RH; Greist JH; Sutherland SM
    J Clin Psychopharmacol; 1999 Aug; 19(4):341-8. PubMed ID: 10440462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
    Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
    Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Placebo-controlled study of gabapentin treatment of panic disorder.
    Pande AC; Pollack MH; Crockatt J; Greiner M; Chouinard G; Lydiard RB; Taylor CB; Dager SR; Shiovitz T
    J Clin Psychopharmacol; 2000 Aug; 20(4):467-71. PubMed ID: 10917408
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin.
    Backonja MM; Canafax DM; Cundy KC
    Pain Med; 2011 Jul; 12(7):1098-108. PubMed ID: 21627766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in Refractory Epilepsy Add-on Treatment.
    Lindberger M; Alenius M; Frisén L; Johannessen SI; Larsson S; Malmgren K; Tomson T
    Epilepsia; 2000 Oct; 41(10):1289-95. PubMed ID: 11051124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.